Price of cancer medicine drops in India

Price of cancer medicine drops in India, revised MRPs of anti-cancer medicines, applicable from November 9, 2026. This is sure to lead to affordable cancer care in the country. The revised MRPs of anti-cancer medicines, effective from today.

Under Trade Margin Rationalisation (TMR), the trade margin on 137 non-scheduled anti-cancer drugs is capped at 30% of MRP. The price of cancer medicine drops in India 1,364 formulations now carry lower prices across the country.

Open the Pharma Sahi Daam app, type the medicine, see its revised MRP — before you pay. Keep the bill. If you are charged more, NPPA is one call away: 1800-111-255.

The Government has capped excessive markups along the pharmaceutical supply chain, in retail and hospital pharmacies across the country, to make cancer treatment in India more affordable.

Companies have reported an average of 20% to 70% in MRP reductions. The highest reduction reported was 96.45% (as on November 4, 2026). Due to these MRP reductions, the estimated savings stand at Rs. 3,357.49 crore (as on November 4, 2026).

The estimate represents the difference between the original and revised prices, applied to the volume sold from April 2025 to March 2026.

The cap responds to concerns raised by State authorities, patients and civil society about the gap between the procurement price and the Maximum Retail Price (MRP) of anti-cancer medicines.

Consumers can verify prices using both the NPPA website and the official Pharma Sahi Daam mobile app. The new prices are worked out from the distributor price of March 2026.

Affordable, quality cancer care for every family is a priority for the Government of India. On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP).

The price of cancer medicine drops revised prices take effect on November 9, 2026. By November 4, 2026, 70 companies had reported revised MRPs for 120 drugs, with the highest reduction at 96.45% and estimated savings of Rs. Rs 3,357.49 crore. MRP reductions average 20% to 70%.

Also Read: 3-storied building collapse in Delhi, several feared trapped
WhatsApp
Follow The Utkal Post on WhatsApp Get the latest Odisha & India news directly on WhatsApp.
Follow

LEAVE A REPLY

Please enter your comment!
Please enter your name here